Skip to main content
SpringerLink
Log in

Anticoagulant sales for STEMI (ST-elevation myocardial infarction) are likely to double over the next decade,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Sales of Anticoagulants for the Treatment of St-Elevation Myocardial Infarction Will Double Over the Next 10 Years. Media Release: 22 Sep 2008. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anticoagulant sales for STEMI (ST-elevation myocardial infarction) are likely to double over the next decade,. Pharmacoecon. Outcomes News 563, 10 (2008). https://doi.org/10.2165/00151234-200805630-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805630-00023

Keywords

Search

Navigation